| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 2,666 | 2,714 | 4,786 | 6,493 | | Cost of Revenue | 2,740 | 2,651 | 2,267 | 2,523 | | | Gross Profit | (74) | 63 | 2,519 | 3,970 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,168 | 3,094 | 3,692 | 3,639 | | Non Recurring | 2,964 | 1 | 135 |
-
| | Others | 34 | 32 | 56 | 61 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,240) | (3,064) | (1,364) | 270 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 688 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,552) | (3,064) | (1,364) | 270 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,552) | (3,064) | (1,364) | 270 | | Income Tax Expense | (45) | (40) |
-
| 80 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,507) | (3,024) | (1,364) | 190 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,507) | (3,024) | (1,364) | 190 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,507) | ($3,024) | ($1,364) | $190 |
|
0.51% Nasdaq 
Income Statement
